Silvia N. Tenembaum and Garrahan JP
The scientific world of central nervous system (CNS) neuroinflammatory disorders in general and multiple
sclerosis (MS) in particular continues to expand, and 2013 has witnessed interesting advances in many aspects of
research. In this review we will discuss research discoveries and results that have contributed to expand our
knowledge in diverse areas of the MS field, including new environmental and genetic risk factors, new lines of
treatment, and biomarkers of treatment response. Finally, new data on diagnostic biomarkers for neuromyelitis
optica (NMO) have emerged, in addition to advances in NMO treatment